Moleculin Biotech, Inc. Effective Tax Rate
Moleculin Biotech, Inc. (MBRX) reported Effective Tax Rate of 0.00% for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Expense Statement › Income Tax
us-gaap:EffectiveIncomeTaxRateContinuingOperations · last filed 2026-08-13
- Moleculin Biotech, Inc. effective income tax rate reconciliation, percent for the quarter ending 2026-03-31 was 0.00%.
- Moleculin Biotech, Inc. effective income tax rate reconciliation, percent for the quarter ending 2025-03-31 was 0.00%.
- Moleculin Biotech, Inc. effective income tax rate reconciliation, percent for the quarter ending 2024-03-31 was 0.00%.
- Moleculin Biotech, Inc. effective income tax rate reconciliation, percent for the quarter ending 2023-03-31 was 0.00%.
- Moleculin Biotech, Inc. effective income tax rate reconciliation, percent for fiscal 2025 was 0.00%.
- Moleculin Biotech, Inc. effective income tax rate reconciliation, percent for fiscal 2024 was 0.00%.
- Moleculin Biotech, Inc. effective income tax rate reconciliation, percent for fiscal 2023 was 0.00%.
- Moleculin Biotech, Inc. effective income tax rate reconciliation, percent for fiscal 2022 was 0.00%.
| Period end | Effective Income Tax Rate Reconciliation, Percent 3 month | Effective Income Tax Rate Reconciliation, Percent 6 month | Effective Income Tax Rate Reconciliation, Percent 9 month | Effective Income Tax Rate Reconciliation, Percent 12 month | Effective Income Tax Rate Reconciliation, Percent 12 month as first filed |
|---|---|---|---|---|---|
| 2026-06-30 | 0.00% 10-Q · filed 2026-08-13 | ||||
| 2026-03-31 | 0.00% 10-Q · filed 2026-05-14 | ||||
| 2025-12-31 | 0.00% 10-K · filed 2026-03-18 | ||||
| 2025-09-30 | 0.00% 10-Q · filed 2025-11-13 | ||||
| 2025-06-30 | 0.00% 10-Q · filed 2026-08-13 | ||||
| 2025-03-31 | 0.00% 10-Q · filed 2026-05-14 | ||||
| 2024-12-31 | 0.00% 10-K · filed 2026-03-18 | ||||
| 2024-09-30 | 0.00% 10-Q · filed 2025-11-13 | ||||
| 2024-06-30 | 0.00% 10-Q · filed 2025-08-12 | ||||
| 2024-03-31 | 0.00% 10-Q · filed 2025-05-13 | ||||
| 2023-12-31 | 0.00% 10-K · filed 2025-03-21 | ||||
| 2023-09-30 | 0.00% 10-Q · filed 2024-11-08 | ||||
| 2023-06-30 | 0.00% 10-Q · filed 2023-08-10 | ||||
| 2023-03-31 | 0.00% 10-Q · filed 2024-08-13 | ||||
| 2022-12-31 | 0.00% 10-K · filed 2024-03-22 | ||||
| 2022-09-30 | 0.00% 10-Q · filed 2023-11-13 | ||||
| 2022-06-30 | 0.00% 10-Q · filed 2023-08-10 | ||||
| 2022-03-31 | 0.00% 10-Q · filed 2023-05-10 | ||||
| 2021-12-31 | 0.00% 10-K · filed 2023-03-22 | ||||
| 2021-09-30 | 0.00% 10-Q · filed 2022-11-10 | ||||
| 2021-06-30 | 0.00% 10-Q · filed 2022-08-12 | ||||
| 2021-03-31 | 0.00% 10-Q · filed 2022-05-11 | ||||
| 2020-12-31 | 0.00% 10-K · filed 2022-03-24 | ||||
| 2020-09-30 | 0.00% 10-Q · filed 2020-11-12 | 0.00% 10-Q · filed 2021-11-10 | |||
| 2020-06-30 | 0.00% 10-Q · filed 2020-08-12 | 0.00% 10-Q · filed 2021-08-11 | |||
| 2020-03-31 | 0.00% 10-Q · filed 2021-05-12 | ||||
| 2019-12-31 | 1.70% 10-K · filed 2021-03-24 | 1.73% 10-K · filed 2020-03-19 | |||
| 2019-09-30 | 5.20% 10-Q · filed 2020-11-12 | 1.40% 10-Q · filed 2020-11-12 | |||
| 2019-06-30 | 0.00% 10-Q · filed 2020-08-12 | 0.00% 10-Q · filed 2020-08-12 | |||
| 2019-03-31 | 0.00% 10-Q · filed 2020-05-11 | ||||
| 2018-12-31 | 0.00% 10-K · filed 2020-03-19 | ||||
| 2017-12-31 | 0.00% 10-K · filed 2019-02-21 | ||||
| 2016-12-31 | 0.00% 10-K · filed 2018-03-28 | ||||
| 2015-12-31 | 0.00% 10-K · filed 2017-04-03 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |
| KALA BIO, Inc. (KALA) | United States | $0.011B | -3.33 |
| Theriva Biologics, Inc. (TOVX) | United States | $0.011B | |
| Dare Bioscience, Inc. (DARE) | United States | $0.011B | |
| Azitra, Inc. (AZTR) | United States | $0.010B | -0.81 |
| Medicus Pharma Ltd. (MDCX) | $0.010B | ||
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| Aprea Therapeutics, Inc. (APRE) | United States | $0.010B | -0.78 |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |